Cheng, Ting-Jen <br/><br/>
Model system for high-throughput screening of novel human immunodeficiency virus protease inhibitors in Escherichia coli.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Jul 2004 
 - 2437-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.48.7.2437-2447.2004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amides--metabolism<br/>Blotting, Western<br/>Cost-Benefit Analysis<br/>Dose-Response Relationship, Drug<br/>Drug Evaluation, Preclinical--economics<br/>Escherichia coli--drug effects<br/>HIV Protease Inhibitors--pharmacology<br/>HIV-1--drug effects<br/>Humans<br/>Mutagenesis<br/>Plasmids--genetics<br/>Reproducibility of Results<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>beta-Galactosidase--metabolism